Dee Faces Herbal Profile
Key Indicators
- Authorised Capital ₹ 12.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 8.51 Cr
as on 17-07-2024
- Company Age 19 Year, 7 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 8.84 Cr
as on 17-07-2024
- Satisfied Charges ₹ 19.00 Cr
as on 17-07-2024
- Revenue -6.18%
(FY 2022)
- Profit 116.49%
(FY 2022)
- Ebitda -2.41%
(FY 2022)
- Net Worth 0.26%
(FY 2022)
- Total Assets -2.33%
(FY 2022)
About Dee Faces Herbal
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 12.00 Cr and a paid-up capital of Rs 8.51 Cr.
The company currently has active open charges totaling ₹8.84 Cr. The company has closed loans amounting to ₹19.00 Cr, as per Ministry of Corporate Affairs (MCA) records.
Ajay Garg and Damodar Aggarwal serve as directors at the Company.
- CIN/LLPIN
U24333DL2005PTC135608
- Company No.
135608
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Apr 2005
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Delhi
Industry
Company Details
- Location
New Delhi, Delhi, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Dee Faces Herbal?
Board Members(2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Ajay Garg | Director | 10-Aug-2007 | Current |
Damodar Aggarwal | Director | 10-Aug-2007 | Current |
Financial Performance and Corporate Structure Insights of Dee Faces Herbal.
Dee Faces Herbal Private Limited, for the financial year ended 2022, experienced Minor drop in revenue, with a 6.18% decrease. The company also saw a substantial improvement in profitability, with a 116.49% increase in profit. The company's net worth moved up by a moderate rise of 0.26%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations | |||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Dee Faces Herbal?
In 2023, Dee Faces Herbal had a promoter holding of 74.74% and a public holding of 25.26%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Smc Real Estate Advisors Private LimitedActive 11 years 10 months
Damodar Aggarwal is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Standard Chartered Bank Creation Date: 30 Jan 2023 | ₹4.00 Cr | Open |
Standard Chartered Bank Creation Date: 30 Dec 2022 | ₹4.84 Cr | Open |
Housing Development Finance Corporation Limited Creation Date: 29 Apr 2013 | ₹19.00 Cr | Satisfied |
How Many Employees Work at Dee Faces Herbal?
Unlock and access historical data on people associated with Dee Faces Herbal, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Dee Faces Herbal, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Dee Faces Herbal's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.